diabetes

Diabetes drug researcher admits drug trials are unethical and dangerous

Monday, October 25, 2010 by: David Gutierrez, staff writer
Tags: drug trials, diabetes, health news

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
NJ cops bust teenagers shoveling snow without a permit
Chemotherapy kills cancer patients faster than no treatment at all
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Whooping cough outbreak at Massachusetts high school affected only vaccinated students
Inuit Elders tell NASA Earth Axis Shifted
Vaccine flu shots still contain 25 micrograms mercury - 100 times the concentration of 'mercury-loaded' fish
Measles outbreak likely caused by vaccinated children, science shows
Baby formula is loaded with GMOs - Avoid these brands
Extreme trauma from male circumcision causes damage to areas of brain
Terminal stage IV lung cancer patient miraculously cured by cannabis oil
Costco stops selling antibiotic laden chicken in response to consumer demand
FDA cracks down Walmart, GNC, other companies selling supplements that do not contain the herbs on the label
McDonald's french fries found to contain Silly Putty ingredient and petroleum chemical

Delicious
(NaturalNews) A drug researcher who presided over the trial that first raised concerns over the diabetes blockbuster Avandia has warned that further tests of the drug's safety would be unethical.

In 2009, David Juurlink of Sunnybrook Health Sciences Center in Toronto was the lead author of a study that compared rates of heart failure and death among older diabetics taking Avandia (known generically as rosiglitazone) and those taking Actos (pioglitazone), another drug in the same family. That study found that patients taking Avandia were 30 percent more likely to suffer heart failure or death.

Now Juurlink has joined with Sidney Wolfe, director of health research for Public Citizen, to call for the cancellation of another planned Avandia-Actos comparison study, known as the Thiazolidinedione Intervention in Vitamin D Evaluation (TIDE) trial.

The TIDE trial is to be performed by Avandia manufacturer GlaxoSmithKline at the behest of the FDA, which in 2007 ordered the company to conduct further safety studies of the drug. The FDA's order came after it required the company to put a "black box" warning on the drug's packaging about the risk of heart attack and heart failure.

The strong results of the 2009 study make any further comparison unethical, Juurlink and Wolfe have warned. The TIDE trial would expose "thousands of high-risk patients with diabetes to a drug with an unfavorable safety profile and clinical advantage over its comparator," they wrote in an open letter to the FDA.

The TIDE study is due to be carried out in 14 different countries, including Third World countries such as Chile, India, Latvia, Mexico and Pakistan.

"[The] price of definitive proof" that Avandia is unsafe, "will almost certainly be measured in the lives of study subjects who have been incompletely informed about the risks and benefits of participation," Wolfe and Juurlink wrote.

All drugs in the thiazolidinedione class, including Actos and Avandia, have also been linked to increased risk of anemia, edema, macular edema, bony fractures and acute liver injury.

Sources for this story include: http://latimesblogs.latimes.com/booster_shot....

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.